The deadlines and procedures are set out in the evaluation result letter. For more information on complaints about proposal rejection: https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Complaints+about+proposal+rejection.

Economic/ technological and Societal impact sub-sections in 2.4 are linked to the (economic) impact. What impact the project results, not only in terms of research results but also in terms of the results of the programme as such (e.g. new concept of training, new approach, etc.).

This section is linked to the European Innovation CAPACITY. It is not focusing on IMPACT (which is strongly linked to the project results) but on CAPACITY or creating critical mass. Thus this section is more linked to the delivery of uniquely trained researchers in a certain topic. This can contribute to the CAPACITY (e.g. next generation researchers that have unique and improved skills and level of expertise compared to the researchers today in and outside Europe, etc.).

For Table 3.1d in case of one researcher with split/ multiple recruitments, the applicant can complete the table only once, listing both/ all recruitments. The same goes for table 1.3a provided that the table is clear and easy to understand and has the information about the two recruitments per fellow.

It would be good to have the eight elements listed on p. 82 of the Work Programme 2021-2022 already in the proposal, however, if the applicants don’t have enough space, REA will add them at the grant agreement preparation phase.

If the fellow was 1) performing their main activity in the lab based abroad and they were physically present there, and/ or 2) they were also residing abroad, then they should be considered eligible for France.

All Open Science aspects are moved under Excellence in the methodology. Open Access should not be described under Impact and Dissemination as it is assessed under Excellence.

This requirement should be applicable to beneficiaries and not to associated partners.

For calls with deadlines in 2022 and beyond, once a project proposal is selected for funding following evaluations, consortium partners concerned by the eligibility criterion will have until Grant Agreement signature to confirm they have a GEP in place.

For calls with deadlines in 2022 and beyond, once a project proposal is selected for funding following evaluations, consortium partners concerned by the eligibility criterion will have until Grant Agreement signature to confirm they have a GEP in place.

This is mainly for statistics purposes.

Yes. Such an additional contract in the US can be for example to ensure equivalent benefits and social security coverage. Below is an example provided by the European Commission:

Example: A BE university recruits the fellow for the total duration of the action (i.e. provides the main employment contract under the action) and sends him/her to a US university. Continuing the Belgian social security during the stay in the US could be too expensive, so that the beneficiary asks the US partner organisation to conclude an additional employment contract, in order to insure the researcher in the US.

Yes, there has to be a transfer of money from the institution of the return phase to the partner hosting the outgoing phase. Partnership agreement should be signed and should define such a transfer. Country correction coefficient (CCC) of the partner hosting the outgoing phase will be applied. The transfer can include not only living allowance but also mobility and family contribution or transfer of institutional contribution.

No. The researcher should be recruited by the institution of the return phase (the European beneficiary) under an employment contract that covers the entire duration of the grant agreement, including the outgoing phase (36 months total). It is then possible for the partner hosting the outgoing phase (the Third country organisation) to sign an additional employment contract with the researcher for just those 24 months of the outgoing phase, but the main contract will be with the beneficiary in Europe. In the practice different scenarios can occur, e.g. for the time of the outgoing phase (i.e. 24 months) the institution of the return phase will provide unpaid leave to the researcher – i.e. the researcher remains employee of the institution of the return phase but receives no salary from this institution.

It may be possible if the challenges are insurmountable.

Firstly, the fellow and the beneficiary should of course try to solve the issues and also document the process.

But if that fails, they should contact their Project Officer. Best practice would be to already be able to suggest an alternative that would ensure that the project could be implemented according to/or as close as possible to what has been evaluated.

The return phase always lasts 12 months, there are no exceptions. Starting at the European institution counts as outgoing. This means that if the outgoing phase is 24 months, only 21 months will be left after the secondment at the European return host.

The first thing to note is, that even though they cannot directly claim costs, it does not mean that they cannot indirectly receive some funding for the role they have in the DN. Typically for each unit cost, there is one part that goes to the researcher and then there is the institutional part, and this part should not be seen as funding for just this particular fellow, and this beneficiary. It is rather a common pot for the whole consortium to run the project. In the consortium agreement the consortium defines how this is split. This funding can be distributed to the different partners according to their needs in the project: some partners provide more trainings, for instance, the coordinator typically has more management costs, so this funding can be redistributed, and some of this money can go to associated partners to cover the costs of them hosting researchers for secondments, or for them to provide trainings. So these are internal arrangements within the consortium (in the broader sense with the associated partners) so they can get indirectly money for their action. Of course, there are also non-financial incentives; the interest for them to participate could be transfer of knowledge or being part of a dynamic network and being associated to the research project.

For PF, direct financial benefits may not be there but there are plenty indirect benefits – scientific contributions, networking, getting experience in this type of projects, hosting events.

All Open Science aspects are moved under Excellence in the methodology. Open Access should not be described under Impact and Dissemination as it is assessed under Excellence.

This requirement should be applicable to beneficiaries and not to associated partners.

For calls with deadlines in 2022 and beyond, once a project proposal is selected for funding following evaluations, consortium partners concerned by the eligibility criterion will have until Grant Agreement signature to confirm they have a GEP in place.

For calls with deadlines in 2022 and beyond, once a project proposal is selected for funding following evaluations, consortium partners concerned by the eligibility criterion will have until Grant Agreement signature to confirm they have a GEP in place.